VYNE THERAPEUTICS INC

CUSIP: 92941V209 Class: Stock

STALEY CAPITAL ADVISERS INC's Holding History (CIK: 0001106565)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 51,472 Value ($000) $30 Avg Close Range
Q3 2025
Shares 51,472 Value ($000) $17 Avg Close Range
Q2 2025
Shares 51,472 Value ($000) $85 Avg Close Range
Q1 2025
Shares 51,472 Value ($000) $81 Avg Close Range
Q4 2024
Shares 36,472 Value ($000) $122 Avg Close Range
Q3 2024
Shares 36,472 Value ($000) $69 Avg Close Range
Q2 2024
Shares 36,472 Value ($000) $72 Avg Close Range
Q1 2024
Shares 36,472 Value ($000) $112 Avg Close Range
Q4 2023
Shares 36,472 Value ($000) $85 Avg Close Range
Q3 2023
Shares 23,472 Value ($000) $95 Avg Close Range
Q2 2023
Shares 23,472 Value ($000) $96 Avg Close Range
Q1 2023
Shares 23,472 Value ($000) $0 Avg Close Range
Q4 2022
Shares 62,500 Value ($000) $0 Avg Close Range
Q3 2022
Shares 62,500 Value ($000) $14 Avg Close Range
Q2 2022
Shares 62,500 Value ($000) $24 Avg Close Range
Q1 2022
Shares 62,500 Value ($000) $41 Avg Close Range
Q4 2021
Shares 62,500 Value ($000) $64 Avg Close Range
Q3 2021
Shares 50,000 Value ($000) $70 Avg Close Range
Q2 2021
Shares 37,500 Value ($000) $132 Avg Close Range
Q1 2021
Shares 25,000 Value ($000) $171 Avg Close Range